Search Results - "Monzr, A.M."

Radiation-Related Late Toxicities Following Total Marrow Irradiation Transplant Conditioning Regimens by Ladbury, C.J., Dandapani, S.V., Han, C., Hui, S.K., Yang, D., Marcucci, G., Rosenthal, J., Monzr, A.M., Nakamura, R., Stein, A., Liu, A., Wong, J.Y.C.

“…Total marrow irradiation (TMI) and total marrow and lymphoid irradiation (TMLI) have been developed as a component of organ sparing myeloablative conditioning…”
Get full text

Phase II Trial of TMLI 20 Gy in Combination with Cyclophosphamide and Etoposide in Patients with Poor-Risk Acute Leukemia by Wong, J.Y.C., Monzr, A.M., Salhotra, A., Dandapani, S.V., Wang, Y., Palmer, J., Han, C., Liu, A., Radany, E.H., Aldoss, I., Ali, H., Farol, L., Sahebi, F., Spielberger, R., Marcucci, G., Nakamura, R., Smith, E., Hui, S.K., Forman, S.J., Stein, A.

“…Patients with relapsed or refractory (R/R) acute leukemia have a poor prognosis with current hematopoietic cell transplant (HCT) options. Total marrow and…”
Get full text

First-in-Human Phase I Trial Combining Biologically Guided Radioimmunotherapy (RIT) Using a 90Y-Anti-CD25 Monoclonal Antibody (Mab) with CT-guided Total Marrow and Lymphoid Irradiation (TMLI) in Relapsed and Refractory (R/R) Acute Leukemia by Wong, J.Y.C., Monzr, A.M., Sahebi, F., Dandapani, S.V., Yamauchi, D.M., Salhotra, A., Adhikarla, V., Ali, H., Poku, E., Yang, D., Han, C., Liu, A., Mokhtari, S., Wu, A., Yazaki, P., Shively, J.E., Hui, S.K., Smith, E., Stein, A.

“…Patients with R/R acute leukemia after allogeneic hematopoietic cell transplant (alloHCT) have a dismal prognosis with 3-year survival rates of < 20%. To…”
Get full text